High levels of IL-17-producing CD4+ T cells have been found in the peripheral blood or cerebrospinal fluid (CSF) of RRMS patients during relapses [65,66,67] and in MS patients with active disease [68]. This evidence concerns the gene IL17A and myeloid sarcoma.